Skip to main content

5 Result(s)

within P. Som Remove this filter

and

  1. No Access

    Article

    Studies of aluminum in rat brain

    The effects of high aluminum concentrations in rat brain were studied using14C autoradiography to measure the uptake of [14C]2deoxy-d-glucose ([14C]2dG) and microbeam proteon-induced X-ray emission (microPIXE) wi...

    J. J. Lipman, A. B. Brill, P. Som, K. W. Jones… in Biological Trace Element Research (1987)

  2. No Access

    Chapter

    The development of radioiodinated 3-methyl-branched fatty acids for evaluation of myocardial disease by single photon techniques

    The measurement of regional myocardial “release-rates” after intravenous administration of iodine-123-labeled fatty acids such as 17-iodoheptadecanoic acid (HDA) [1–6] and 15-(p-iodophenyl)pentadecanoic acid (...

    F. F. Knapp Jr, M. M. Goodman, K. R. Ambrose… in Noninvasive Imaging of Cardiac Metabolism (1987)

  3. No Access

    Article

    97Ru-transferrin uptake in tumor and abscess

    The uptake of97Ru-transferrin (Ru-TF) in tumor and abscess bearing animals was compared with67Ga-citrate (Ga),123I-transferrin (I-TF), and several other plasma proteins. Maximal concentration in tumor of Ru-TF in...

    P. Som, Z. H. Oster, K. Matsui, G. Guglielmi… in European Journal of Nuclear Medicine (1983)

  4. No Access

    Article

    The effect of diphenylhydantoin (Dilantin) on thallium-201 chloride uptake

    The effect of diphenylhydantoin (Dilantin) on the myocardial uptake of 201Tl-chloride was studied in rats. Prior administration of Dilantin caused a significant (38.8) decrease in 201Tl uptake compared with the c...

    E. R. Schachner M.D., Z. H. Oster, N. R. Cicale… in European Journal of Nuclear Medicine (1981)

  5. No Access

    Chapter and Conference Paper

    Ruthenium-97 Labeled Compounds — a New Class of Radiopharmaceuticals

    The excellent physical properties of ruthenium-97 (216 KeV γ, 86%) with a half-life of 2.9 days combined with its chemical reactivity make it attractive as a label for versatile new radiopharmaceuticals. Sever...

    S. C. Srivastava, P. Richards, P. Som, G. Meinken… in Frontiers in Nuclear Medicine (1980)